US BioPharmaceutical company, Merck, to make the treatment available to millions of people in mostly low- and middle-income nations.
World
US BioPharmaceutical company, Merck, to make the treatment available to millions of people in mostly low- and middle-income nations.
World
More Stories
New Breakthrough for Brain and Spinal Cord Gene Delivery Systems
How the Child Support System Violates the U.S. Constitution
“Big Bad Tax Bill” Squeaks Through House by Single Vote in Late-Night Drama